Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.48%15.7B | -2.55%3.33B | 5.45%4.71B | 5.52%15.03B | 6.54%3.56B | 0.93%3.58B | 1.26%3.42B | 12.38%4.46B | 20.32%14.24B | -0.43%3.34B |
| Cost of revenue | 6.26%7.65B | 1.36%1.6B | 6.67%2.28B | 2.49%7.2B | 2.96%1.74B | 0.19%1.74B | -4.75%1.58B | 10.35%2.14B | 12.89%7.02B | -5.37%1.69B |
| Gross profit | 2.84%8.05B | -5.91%1.73B | 4.33%2.43B | 8.47%7.83B | 10.17%1.83B | 1.65%1.84B | 7.07%1.84B | 14.32%2.33B | 28.56%7.22B | 5.15%1.66B |
| Operating expense | 6.84%7.81B | 5.13%1.9B | 5.63%1.88B | 6.25%7.31B | 3.49%1.94B | 9.25%1.79B | 6.09%1.81B | 6.57%1.78B | 1.16%6.88B | 10.34%1.87B |
| Staff costs | ---- | ---- | ---- | 2.77%4.43B | ---- | ---- | ---- | ---- | -1.13%4.31B | ---- |
| Selling and administrative expenses | ---- | ---- | ---- | 11.74%1.31B | ---- | ---- | ---- | ---- | 8.48%1.17B | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | 24.48%463.73M | ---- | ---- | ---- | ---- | 33.63%372.52M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 5.81%846.67M | ---- | ---- | ---- | ---- | -0.26%800.21M | ---- |
| Depreciation and amortization | ---- | ---- | ---- | 13.74%264.32M | ---- | ---- | ---- | ---- | 10.66%232.39M | ---- |
| -Depreciation | ---- | ---- | ---- | 13.74%264.32M | ---- | ---- | ---- | ---- | 10.66%232.39M | ---- |
| Rent and land expenses | ---- | ---- | ---- | 5.76%561.5M | ---- | ---- | ---- | ---- | 3.29%530.91M | ---- |
| Other operating expenses | ---- | ---- | ---- | 17.57%739.39M | ---- | ---- | ---- | ---- | -0.40%628.92M | ---- |
| Operating profit | -53.27%243.03M | -599.26%-167.76M | 0.11%547.92M | 53.41%520.09M | 47.80%-112.69M | -70.08%51.89M | 111.95%33.6M | 49.68%547.29M | 128.59%339.02M | -77.83%-215.88M |
| Net non-operating interest income (expenses) | 13.71%-10.33M | 13.86%-2.54M | 12.58%-2.8M | 37.89%-11.97M | 12.99%-2.77M | 17.17%-3.05M | 43.08%-2.95M | 55.66%-3.2M | 54.36%-19.26M | 63.43%-3.18M |
| Non-operating interest income | 28.32%444K | -13.07%153K | --0 | -15.40%346K | -10.05%170K | --0 | -14.98%176K | --0 | -26.96%409K | -31.02%189K |
| Non-operating interest expense | -12.53%10.77M | -13.82%2.69M | -12.58%2.8M | -37.42%12.31M | -12.83%2.94M | -17.28%3.05M | -42.00%3.13M | -55.71%3.2M | -54.00%19.67M | -62.44%3.37M |
| Net investment income | 17.92%45.14M | 25.03%23.73M | -5.97%3.03M | -13.08%38.28M | 11.97%14.11M | 19.05%1.98M | -28.25%18.98M | -3.39%3.22M | 7.40%44.04M | 0.45%12.6M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -81.73%85.13M | 56.03M | 0 | 607.80%465.98M | 0 | 0 | 0 | 465.98M | 4.54%65.84M | 126.98%6.8M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 95.95%-6.5M | 0 | 0 | -546.38%-160.32M | 101.65%354K | 0 | -1,241.79%-161.02M | 45.30%340K | -101.91%-24.8M | 94.20%-21.4M |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -89.15%31.45M | --11.22M |
| Less:Other special charges | ---- | ---- | ---- | 97.90%-354K | ---- | ---- | ---- | ---- | 99.00%-16.83M | --0 |
| Less:Write off | -95.96%6.5M | --0 | --0 | 1,478.34%160.68M | --0 | --0 | --161.02M | ---340K | -89.15%10.18M | -87.10%10.18M |
| Other non-operating income (expenses) | -2.30%69.78M | -17.64%15.59M | -4.49%17.08M | -16.49%71.42M | -16.55%17.51M | 1.96%17.09M | -28.95%18.93M | -15.34%17.89M | -68.63%85.52M | -79.01%20.98M |
| Income before tax | -53.84%426.25M | 18.93%-74.95M | -45.20%565.22M | 88.34%923.48M | 58.27%-83.49M | -69.60%67.92M | -210.19%-92.46M | 169.25%1.03B | 9.14%490.34M | 51.38%-200.09M |
| Income tax | -159.51%-74.32M | 93.33%-5.74M | -39.98%102.6M | 535.56%124.9M | 121.36%19.21M | -45.94%20.81M | -582.92%-86.05M | 3,362.84%170.93M | -119.13%-28.68M | -66,219.85%-89.92M |
| Net income | -37.32%500.57M | -979.44%-69.21M | -46.24%462.63M | 53.86%798.58M | 6.78%-102.69M | -74.53%47.1M | -109.70%-6.41M | 127.57%860.58M | 73.38%519.02M | 73.24%-110.16M |
| Net income continuous operations | -37.32%500.57M | -979.61%-69.21M | -46.24%462.63M | 53.87%798.58M | 6.78%-102.69M | -74.53%47.1M | -109.70%-6.41M | 127.57%860.58M | 73.38%519.01M | 73.24%-110.17M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -37.32%500.57M | -979.44%-69.21M | -46.24%462.63M | 53.86%798.58M | 6.78%-102.69M | -74.53%47.1M | -109.70%-6.41M | 127.57%860.58M | 73.38%519.02M | 73.24%-110.16M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -37.32%500.57M | -979.44%-69.21M | -46.24%462.63M | 53.86%798.58M | 6.78%-102.69M | -74.53%47.1M | -109.70%-6.41M | 127.57%860.58M | 73.38%519.02M | 73.24%-110.16M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -37.69%145.4 | -796.04%-20.34 | -46.58%134.84 | 52.94%233.35 | 7.13%-30.21 | -75.29%13.4 | -111.77%-2.27 | 126.19%252.43 | 72.29%152.58 | 73.33%-32.53 |
| Diluted earnings per share | -37.69%145.4 | -796.04%-20.34 | -46.58%134.84 | 52.94%233.35 | 7.13%-30.21 | -75.29%13.4 | -111.77%-2.27 | 126.19%252.43 | 72.29%152.58 | 73.33%-32.53 |
| Dividend per share | 50.00%45 | 0 | 0 | 50.00%30 | 50.00%30 | 0 | 0 | 0 | 20 | 20 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |